St. Louis, MO
Home ► Blog ► Bad Drugs and Marketing
The FDA released a public safety alert, warning type 2 diabetes patients taking SGLT-2 inhibitors that they may be at risk of developing necrotizing fasciitis of the genitals and genital area. Necrotizing fasciitis of the genital area, also called Fo Read More »
Big Pharma’s monopoly over the generic drugs industry has for years been cause for concern for U.S. hospital systems, which frequently deal with drug scarcity and manipulation of drug prices brought on by the pharmaceutical industry. Now, some Read More »
Do you think opioid addiction is becoming an epidemic? Between 2010 and 2016, opioid addiction increased by an outstanding amount – 493%, according to a study conducted by Blue Cross Blue Shield of its members. According to new research, opioid ad Read More »
According to a study released in the American Journal of Public Health earlier this month, 68,177 American physicians received payouts totaling more than $46 million from prescription opioid manufacturers from 2013 to 2015. Drug overdose has become t Read More »
Last month at the American Diabetes Association’s (ADA) 77th Scientific Sessions, AstraZeneca Plc. presented new data supporting the safety and effectiveness of their SLGT-2 inhibitor Farxiga. This data is in direct contention with the FDA̵ Read More »
According to a report by the Institute for Safe Medication Practices (ISMP), the FDA’s Adverse Event Reporting System (FAERS) is flawed and needs modernization. ISMP’s report is based on the analysis of 847,039 reports gathered over Read More »
Today, drug companies spend $4 billion a year on ads to consumers. In 1997, the FDA rules governing pharmaceutical advertising changed, and now companies can name both the drug and what it’s for, while only naming the most significant potential Read More »
Contact us by phone at 1-888-508-6752 or email us below.
© 2017 TorHoerman Law LLC.
The contents of this webpage have been prepared by TorHoerman Law, LLC for informational purposes only. None of this information is intended as either legal or medical advice or opinions. No attorney/client relationship is established with use of this website. Sending or receiving information through this site, posting to our blogs/news site does not establish an attorney/client relationship. An attorney/client relationship with TorHoerman Law is established only by an express and written agreement by TorHoerman Law to represent you. Our attorneys make a case-by-case assessment of any claims and results may vary depending on the facts concerning any case. The attorneys at TorHoerman Law are licensed to practice in Illinois, Missouri, and California. In some circumstances, cases may be sent to other qualified lawyers. In those circumstances, TorHoerman Law maintains joint responsibility.
Wesite Design & Development by Kaizen Coding